National Cancer Registry

National Cancer Registry (NCR)

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

...

190

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01MA12	LEVOFLOXACIN COOPER	G	Levofloxacin (hemihydrate) - 500mg/100ml	500mg/100ml	Injectable solution	959,504 L.L
M01AB55	PANCLO B12	G	Diclofenac sodium - 75mg, Betamethasone disodium phosphate - 2mg, Hydroxocobalamin sulphate - 10mg		Injectable solution	1,158,392 L.L
N01BB03	MEDICAINE 3% SANS VASOCONSTRICTEUR	G	Mepivacaine HCl - 3%	3%	Injectable solution	954,128 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l		Injectable solution	629,916 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 1%	1%	Injectable solution	1,732,213 L.L
J01MA12	LEVOFLOXACIN- HAMELN	G	Levofloxacin - 500mg/100ml	5mg/ml	Injectable solution	1,632,769 L.L
M01AB55	DIFEN B12	G	Diclofenac sodium - 75mg, Prednisolone sodium phosphate - 10.08mg, Hydroxocobalamin acetate - 10.44mg		Injectable solution	978,317 L.L
N01BB03	SCANDINIBSA	G	Mepivacaine HCl - 3%	3%	Injectable solution	1,191,988 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l		Injectable solution	769,337 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 3%	3%	Injectable solution	2,576,146 L.L
J01MA12	LEVOFLOXACIN NORMON	G	Levofloxacin - 500mg/100ml	5mg/ml	Injectable solution	27,147,388 L.L
N01BB09	ROPIVACAINA MOLTENI	G	Ropivacaine HCl - 75mg/10ml	7.5mg/ml	Injectable solution	2,332,911 L.L
B05D	CAPD/DPCA 2Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Glucose monohydrate - 16.5g/l		Injectable solution	735,741 L.L
J01MA12	LEVOFLOXACINA BASI	G	Levofloxacin - 5mg/ml	5mg/ml	Injectable solution	56,572,950 L.L
M01AC01	INFLACAM	G	Piroxicam - 20mg/ml	20mg/ml	Injectable solution	193,513 L.L
N01BB09	ROPIVACAINE B. BRAUN	G	Ropivacaine HCl - 75mg/10ml	7.5mg/ml	Injectable solution	4,831,114 L.L
B05D	CAPD/DPCA 3Solution for peritoneal dialysis	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 42.50g/l, Glucose monohydrate - 46.75g/l		Injectable solution	769,337 L.L
J01MA12	LEVOFLOX-MEDIS 500	G	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	1,834,345 L.L
M01AC01	INFLACAM	G	Piroxicam - 20mg/ml	20mg/ml	Injectable solution	190,826 L.L
N01BB52	DILOCAIN 2%	G	Lidocaine HCl - 20mg/1.7ml, Epinephrine (bitartrate) - 0.0125mg/1.7ml		Injectable solution	2,768,316 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l		Injectable solution	744,140 L.L
J01MA12	LEVOXIPOLIN	G	Levofloxacin (hemihydrate) - 500mg/100ml	500mg/100ml	Injectable solution	1,014,601 L.L
L03AA02	NEOGRASTIM 30	BioTech	Filgrastim - 300mcg/ml	300mcg/ml	Injectable solution	1,970,969 L.L
N01BB53	MEDICAINE 2% WITH ADRENALINE	G	Mepivacaine HCl - 36mg/1.8ml, Epinephrine (tartrate) - 0.032mg/1.8ml		Injectable solution	1,652,926 L.L
N05CM18	PRECEDEX (DEXMEDETOMIDINE)	B	Dexmedetomidine HCl - 200mcg/2ml	200mcg/2ml	Injectable solution	19,441,512 L.L
A10AB01	ACTRAPID	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable solution	752,552 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l		Injectable solution	744,140 L.L
J01MA12	LOXAMOX	G	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	747,176 L.L
L03AA02	NEUTROMAX	BioTech	Filgrastim - 300mcg/ml	300mcg/ml	Injectable solution	2,553,301 L.L
A10AB01	ACTRAPID	BioTech	Insulin (human) - 100IU/ml	100IU/ml	Injectable solution	752,552 L.L

...

190